Neith Corporation (TPEX:6236)
Taiwan · Delayed Price · Currency is TWD 18.00
0.00 (0.00%)
Apr 14, 2026, 11:24 AM CST
Neith Market Cap
Neith has a market cap or net worth of 749.77 million as of April 20, 2026. Its market cap has decreased by -36.84% in one year.
Market Cap
749.77M
Enterprise Value
615.56M
Revenue
36.15M
Ranking
n/a
PE Ratio
237.42
Stock Price
18.00
Market Cap Chart
Since November 3, 2004, Neith's market cap has increased from 483.77M to 749.77M, an increase of 54.99%. That is a compound annual growth rate of 2.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 14, 2026 | 749.77M | -16.47% |
| Dec 30, 2025 | 897.64M | -27.93% |
| Dec 27, 2024 | 1.25B | -13.21% |
| Dec 29, 2023 | 1.43B | 166.67% |
| Dec 30, 2022 | 538.12M | 47.83% |
| Dec 30, 2021 | 364.02M | 7.98% |
| Dec 28, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Meribank Biotech | 1.16B |
| GeneReach Biotechnology | 1.13B |
| Level Biotechnology | 1.09B |
| Lukas Biomedical | 1.03B |
| TCI GENE | 967.06M |
| Taiwan Advance Bio-Pharmaceutical | 945.00M |
| NatureWise Biotech & Medicals | 900.10M |
| BioLASCO Taiwan | 778.60M |